PhaseV specializes in enhancing clinical trial design and execution through advanced algorithms like reinforcement learning and causal ML. By focusing on adaptive trials, they aim to improve success rates and optimize resource use. Their technology is adept at uncovering hidden signals in data and providing actionable insights from clinical trial results.
No recent deals for this company.